| Dr Jean-Pierre Bru Although procalcitonin (PCT) has been proposed for stewardship programs (including in ICU) to reduce the initiation and continuation of unnecessary … Suite
| Dr Jean-Pierre Bru Progress to a slowly or non-resolving form after a Legionnaires’ disease (LD) is a rare event. The aim of this … Suite
| Dr Jean-Pierre Bru As penetration of caspofungin into the human central nervous system (CNS) is known to be limited, this study aimed to … Suite
| Dr Jean-Pierre Bru (1, 3)-β-D-glucan (BDG) is a major cell-wall constituent of most pathogenic fungi. It is widely used as a surrogate marker … Suite
| Dr Olivier Leroy Gram-negative bacilli and especially P. aeruginosa are responsible for increasingly multi-drug resistance challenging problems. The association between a new cephalosporin … Suite
| Dr Jean-Pierre Bru Most of the current guidelines for the management of infective endocarditis (IE) recommend prolonged intravenous antibiotic courses without any oral … Suite
| Dr Jean-Pierre Bru Dalbavancin is a lipoglycopeptide has a potent activity against Gram positive microorganisms, a long half-life (T1/2 160 – 240 h), … Suite
| Dr Philippe Lesprit Antibiotic use is the most important risk factor for the development of Clostridioides difficile infection (CDI). CDI risk is driven … Suite
| Dr Jean-Pierre Bru Suppressive antibiotic therapy (SAT) can be defined as the indefinite administration of antibiotics with the objective of reducing the patient’s … Suite
| Dr Olivier Leroy Survival following lung transplantation continues to improve. However, lung transplant recipients remain at substantial risk for the development of invasive … Suite
